Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to DO2002000517ApriorityCriticalpatent/DOP2002000517A/es
Publication of DOP2002000517ApublicationCriticalpatent/DOP2002000517A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a un polimorfo de la sal citrato de 4-(3,4-diclorofenil)-2-[2-(4-metil piperazin-1-il)benciliden]tiomorfolin-3-ona: y sus composiciones farmacéuticas.
DO2002000517A2002-11-202002-11-20Sal de acido cintrico de un compuesto terapeutico y composiciones farmaceuticas que la contienen.
DOP2002000517A
(es)
3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof